ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC
N. L. Tran, J. Jiang, M. Ma, G. E. Gadbois, K. C. M. Gulay, A. Verano, H. Zhou, C.-T. Huang, D. A. Scott, A. G. Bang, H. Tiriac, A. M. Lowy, E. S. Wang, F. M. Ferguson
This study develops ZBTB11 degraders to target metabolic vulnerabilities in K-Ras inhibitor-resistant PDAC, showing improved anti-cancer activity with reduced toxicity to neurons.
bioRxiv · May 19, 2024 · PreprintCancer Biology